CVRx Investor Relations Material
Latest events
Q2 2025
CVRx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CVRx Inc
Access all reports
CVRx Inc. is a medical device company focused on developing neuromodulation technologies for cardiovascular conditions. The company’s implantable systems are designed to stimulate specific nerves to address heart failure and hypertension. CVRx markets its products to healthcare providers through a direct sales force and distribution network. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.
Key slides for CVRx Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CVRX
Country
🇺🇸 United States